Global Peripheral Vascular Devices Market Size study, by Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alterat

Global Peripheral Vascular Devices Market Size study, by Type (Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices) and Regional Forecasts 2024-2032

The global Peripheral Vascular Devices Market was estimated at USD 9,757.8 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2032. Peripheral vascular devices are critical in the treatment of peripheral vascular diseases (PVDs), which affect blood circulation outside the heart. These conditions can lead to spasms, blockages, or narrowing of the blood vessels, affecting veins and lymphatic vessels, particularly those supplying blood to the legs and brain. As these body parts rely on proper blood flow to function effectively, PVDs can significantly impact health, particularly in the legs and feet, which are most commonly affected.

The aging population, sedentary lifestyles, and the rising prevalence of diabetes and smoking contribute to the growing incidence of Peripheral Artery Disease (PAD), a major subset of PVD. This surge in PAD cases drives the demand for peripheral vascular devices used in both diagnostic and therapeutic interventions. Increased awareness about PAD and advancements in diagnostic techniques have improved early disease detection, thereby increasing the number of patients requiring medical interventions and driving market growth. Despite these growth drivers, the market faces challenges from highly effective alternative treatments, particularly anticoagulant drugs like Dabigatran, which are widely used due to their high efficacy and tolerability. Other medications, such as vasodilators, cholesterol-lowering drugs, and antiplatelet medicines, also serve as alternatives to PAD treatment, posing a significant hurdle to the expansion of peripheral vascular devices. Also, governments, healthcare entities, and patients are increasingly adopting novel technologies that offer enhanced clinical outcomes and quicker recovery periods, further boosting market growth. As PAD is more prevalent among the elderly, the rising aging population globally is expected to increase the number of patients requiring vascular interventions, thereby fostering demand for peripheral vascular devices.

The key regions considered for the Global Peripheral Vascular Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the peripheral vascular devices market with a revenue share of 39.5%, driven by factors such as the increasing incidence of cardiovascular diseases and a growing geriatric population. The presence of major industry players and their strategic initiatives, including collaborations, mergers, partnerships, and novel product launches, further boost market growth. Europe is anticipated to grow at the fastest CAGR during the forecast period, due to its aging population and rising prevalence of vascular diseases, coupled with continuous advancements in medical technology fostering the development of minimally invasive vascular intervention devices.

Major market players included in this report are:

Abbott Laboratories

Angioscore Inc.

Edward Lifesciences Corporation

Medtronic Inc.

St. Jude Medical

Teleflex Medical

Volcano Corporation

Boston Scientific Corporation

Teleflex Medical

Cook Group Inc.

The detailed segments and sub-segment of the market are explained below:

By Type:
• Peripheral Stents
• PTA Balloons
• Catheters
• Endovascular Aneurysm Repair Stent Grafts
• Plaque Modification Devices
• Peripheral Accessories
• Inferior Vena Cava Filters
• Hemodynamic Flow Alteration Devices

By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2030

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2024 to 2030.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.